SSE PLC — Director's Dealing 2026

Feb 4, 2026

National Storage Mechanism | Additional information

RNS Number : 7322R

SSE PLC

04 February 2026

SSE PLC

Director/PDMR Shareholding

Notification of Transactions of Directors/Persons Discharging Managerial Responsibilities (PDMRs)

The Company was notified on 3 February 2026 of participation in the Scrip Dividend alternative for the interim dividend for the year ending 31 March 2026 by a nominee provider on behalf of Sir John Manzoni (Chair), pursuant to a regular standing order instruction.

This announcement is made in accordance with Article 19 of the Market Abuse Regulation ("MAR"). In accordance with MAR, the relevant Financial Conduct Authority ("FCA") notifications are set out in the table below which provides further details on the number of shares acquired on 30 January 2026.

1	Details of the person(s) discharging managerial responsibilities/person closely associated with
a)	Name(s)	Sir John Manzoni (Chair)
2	Reason for the notification
a)	Position/status	As noted in 1a) above
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	SSE plc
b)	LEI	549300KI75VYLLMSK856
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 50pence each fully paid ISIN: GB0007908733
b)	Nature of transaction	Participation in the Scrip Dividend alternative by a nominee provider.
c)	Price(s) and volume(s)	Price: GBP £21.46 Volume: 28 Ordinary shares
d)	Aggregated information -      Aggregated volume -      Price	As noted in 4c) above As noted in 4c) above
e)	Date of transaction	30 January 2026
f)	Place of transaction	London Stock Exchange Main Market XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSSLFFLEMSELE